Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

World Congress of Bronchology and Interventional Pulmonology 2026

We are excited to announce that the World Congress of Bronchology and Interventional Pulmonology 2026 will be hosted by the Thoracic Society of Australia and New Zealand in the vibrant city of Melbourne, Australia. We are excited to announce that...

3rd Global Summit on Heart and Cardiovascular Care 2026

3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress 2026), taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the...

6th International Conference on Cardiology 2026

on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will take place on November 13–14, 2026. 6th International Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will...

Global Pharma Supply Chain & Logistics Forum 2026

The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma...

2nd International Conference on Drug Discovery 2026

The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis Conferences, aims to bring together researchers, scientists, industry leaders, and academicians from around the world to explore groundbreaking innovations in drug...

5th MENA Congress for Rare Diseases 2026

5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel, Abu Dhabi, United Arab Emirates. 5th MENA Congress for Rare Diseases 2026 will take place from 3 to 5 September 2026 at Beach Rotana Hotel,...

Pharmacy Education 2026

Pharmacy Education 2026 is your chance to grow, learn, and lead. Don’t miss the professional development event everyone will be talking about—join us in Grapevine, Texas, July 18-21, for bold ideas, powerful connections, and real-world impact....

23rd International conference on Nanosciences and Nanotechnologies

NN Conference is a world-class International event in Nanosciences and Nanotechnologies (N&N) that focuses on the latest advances on N&N and promotes profound scientific discussions between scientists, researchers from different disciplines and...

Nnamdi Njoku Named President of Omnicell

medication management, announced that Nnamdi Njoku has been appointed President of the Company, effective July 1, 2026. Mr. Njoku will retain his role of Chief Operating Officer (COO), while Randall Lipps will continue to serve as Chief Executive...

Eligible Medicare Beneficiaries Living with Obesity Can Now Access Wegovy® Through the Medicare GLP-1 Bridge

for all strengths of Wegovy® pill includes Novo Nordisk Inc. partner-reported paid claims only from January 5, 2026 through June 2, 2026. †Terms apply. For eligible Medicare patients prescribed Wegovy® for a covered FDA-approved indication....

Avenacy Announces the U.S. Launch of Bortezomib for Injection

standards. U.S. sales of Bortezomib for Injection were approximately $43 million for the twelve months ending in March 2026.¹ Indications Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle...

EVERY and Huvepharma Announce Fourfold Expansion of Production Capacity

made via fermentation. The expansion follows a period of rapid commercial growth for EVERY: in the first four months of 2026, the company secured annual orders worth 550% of its total 2025 order volume. This surge is driven by strong adoption...

Results from Incyte’s Phase 3 frontMIND Trial of Tafasitamab Combination Show Prolonged Progression-Free Survival Presented at EHA 2026

These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 -...

DIA Global Annual Meeting

The DIA 2026 Global Annual Meeting is evolving, just like the life sciences community it serves. Join global innovators, regulators, academics, patient advocates, and industry leaders for an all-new experience designed to inspire, engage, and...

AbbVie Presents EHA 2026 Data on VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Nine-Year Outcomes

AbbVie announced new Phase 3 data on a fixed-duration venetoclax-based combination. Final results from the Phase 3 CLL14 trial in previously untreated chronic lymphocytic leukemia (CLL), which was conducted in collaboration with the German CLL...

IMAAVY® (nipocalimab-aahu) demonstrated rapid onset and durable hemoglobin response in a pivotal Phase 2/3 study of warm autoimmune hemolytic anemia (wAIHA), a disease with no FDA-approved therapies

mean Hgb improvement of at least 1g/dL as early as Week 1.1,c To be presented at the European Hematology Association (EHA) 2026 Congress, these results mark an important step forward for people living with wAIHA, a rare, life-threatening condition...

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

in radiance and fine lines/wrinkles with visible reduction in pore size. About Beauty Crush Skincare Launched in 2026, Beauty Crush represents the culmination of over two decades of award-winning skincare innovation by Karen Behnke. Headquartered...

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

medical imaging continuing to grow, Brain Navi plans to begin a full-scale market push in Taiwan in the second-half of 2026 and will be working closely with medical institutions, distribution partners, and clinical professionals to accelerate the...

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

SK bioscience announced that it has been designated as a supplier of influenza vaccines for UNICEF's 2026 immunization programs and has begun shipments for countries in the Southern Hemisphere. Beginning in September, the company will also...

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

pharmacies and other approved healthcare distribution partners, starting in Germany, Austria, and Switzerland on June 1, 2026, with further roll-out across various countries planned over the next two years. About Ascensia Diabetes Care Ascensia...

Results 1 - 20 of 82